Sanofi Quietly Terminated RSV Infant Vaccine Trial After Baby Death, Cited Ineffectiveness Not Safety
Documents obtained through a FOIA request reveal that a child died during Sanofi’s RSV infant vaccine trial — a fact not included in the company’s public announcement when it quietly ended the trial in October 2024, citing only poor efficacy.




